Edwards Sapien - Model XT - Transcatheter Heart Valves for Predictable Deployment

Sustained freedom from re-intervention for patients with a history of pulmonary valve disease*

COMPASSION trial results using the 23 mm and 26 mm SAPIEN valve, valve implant population (n=69).
^†COMPASSION trial results using the 23 mm and 26 mm SAPIEN valve, attempted implant population (n=70). Device success is defined as deployment of the valve to the target area, removal of the delivery catheter and improvement in regurgitation to none, trace, or mild.
^‡Number at risk: 1 year = 57, 2 years = 45, 3 years = 41, 4 years = 23, 5 years = 9.